Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-11-14

Clinical Trial Update: Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prednisolone to vigabatrin for first-line treatment of infantile spasms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prednisolone (Prednisolone)
  • Vigabatrin (Vigabatrin)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Infantile Spasms | Phase 3 | Status: WITHDRAWN